Evaluating the benefit of adaptive randomization in the CC-115 arm of the Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A phase II randomized Bayesian adaptive platform trial in newly diagnosed MGMT unmethylated glioblastoma.

被引：5

作者：

Rahman, Rifaquat

Trippa, Lorenzo

Fell, Geoffrey

Lee, Eudocia Quant

Arrillaga-Romany, Isabel

Touat, Mehdi

Drappatz, Jan

Galanis, Evanthia

Ahluwalia, Manmeet Singh

Colman, Howard

Nabors, Louis B.

Hepel, Jaroslaw T.

Schiff, David

Welch, Mary Roberta

Meredith, David M.

Chiocca, E. Antonio

Reardon, David A.

Ligon, Keith L.

Alexander, Brian Michael

Wen, Patrick Y.

机构：

[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

[6] Hop La Pitie Salpetriere, Villejuif, France

[7] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA

[8] Mayo Clin, Rochester, MN USA

[9] Taussig Canc Inst, Neurol Inst, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH USA

[10] Cleveland Clin, Cleveland, OH 44106 USA

[11] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[12] Univ Alabama Birmingham, Birmingham, AL USA

[13] Tufts Univ, New England Med Ctr, East Greenwich, RI USA

[14] Univ Virginia, Charlottesville, VA USA

[15] Montefiore Med Ctr, New York, NY USA

[16] Harvard Med Sch, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[17] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[18] Harvard Med Sch, Boston, MA 02115 USA

[19] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.2006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2006

引用

页数：3